Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Companion Animals

Set Alert for Companion Animals

Zoetis launches Stablelab equine blood diagnostic for infection detection

Zoetis has added a new handheld equine blood testing device to its portfolio of diagnostics.

Zoetis Equine

IDEXX highlights blockbuster potential for preventative pet diagnostics

IDEXX Laboratories has emphasized the large addressable market for companion animal diagnostics, especially with the growing adoption of preventative testing.

IDEXX Laboratories Diagnostics

Better Choice to assess CBD efficacy in treating canine anxiety

US pet health specialist Better Choice is working on clinical studies on the potential of cannabidiol (CBD) products to reduce anxiety in dogs.

R&D Canine

ADB to launch redworm blood test diagnostic for horses

UK firm Austin Davis Biologics (ADB) will introduce a small redworm blood test as a diagnostic service for horses in September 2019.

Equine Diagnostics

Merck gains Estrumate US supplemental approval

The US FDA has handed a supplemental approval to Merck Animal Health for its Estrumate (cloprostenol injection) reproductive injectable for cows.

Merck MSD Animal Health Zoetis

MSD adds to Bravecto, Porcilis and Bovilis ranges with European approvals

European authorities have approved MSD Animal Health's Bravecto Plus (fluralaner/moxidectin) for the treatment of ear mites in cats.

Merck MSD Animal Health Product Approvals

US firm launches veterinary diagnostics subsidiary, appoints CEO

Texas-based Volition has established Volition Veterinary Diagnostics (VVG) a veterinary subsidiary to its human life sciences division.

Diagnostics Cancer

KindredBio plans parvovirus mAb launch in next two years, claims 'blockbuster' pipeline potential

Kindred Biosciences chief executive Richard Chin has said the firm is aiming to launch its monoclonal antibody candidate against canine parvovirus by the end of 2020 or early 2021. 

Kindred Biosciences R&D

Zomedica develops first POC assays for Truforma, plans Q1 2020 launch

Zomedica Pharmaceuticals has developed two new assays for its Truforma point-of-care (POC) biosensor platform.

Companion Animals Diagnostics

First signs of Nexvet pipeline come to light with new Zoetis cat mAb

Zoetis expects to gain approval for a new monoclonal antibody (mAb) to control pain associated with osteoarthritis in cats in 2021.

Feline Zoetis

Bioceltix: Stem cell pathway made easier by first European commercialization

Polish start-up Bioceltix is seeking EU Good Manufacturing Practice certification to produce its mesenchymal stromal cell product candidates by the end of 2019.

Companion Animals Operations

Intervacc takes one step closer to European submission for horse vaccine

Swedish business Intervacc has finalized production of its vaccine for equine strangles on a commercial scale.

Vaccines Equine
See All